RNU6-1038P

Across TCGA pan-cancer cohorts, RNU6-1038P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-1038P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1038P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1038P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

KIRC, LUSC, and LIHC are the cancer types where RNU6-1038P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.663	0.814	<.001	114	view →
LUSC	OS	Tertile	II,III,IV	0.203	0.636	<.001	105	view →
LIHC	OS	Tertile	All	0.152	0.692	<.001	72	view →
BRCA	DFS	Tertile	All	0.335	0.529	.002	54	view →
BLCA	DFS	Tertile	III,IV	0.155	0.473	.017	18	view →
PRAD	DFS	Tertile	All	0.098	0.776	<.001	18	view →
ESCA	DFS	Tertile	II,III,IV	0.131	0.776	.043	9	view →
OV	DFS	Tertile	All	0.441	0.151	.041	6	view →
STAD	DFS	Quartile	IV	0.083	0.346	.002	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-1038P–KIRC (OS)

Open the KIRC breakdown →